MIR6078

Across TCGA pan-cancer cohorts, MIR6078 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR6078 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR6078 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6078 expression acts as an unfavorable survival marker.

STAD, PAAD, and LGG are the cancer types where MIR6078 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	III,IV	0.052	0.629	<.001	72	view →
PAAD	DFS	Tertile	All	0.118	0.468	.012	45	view →
LGG	OS	Tertile	All	0.148	0.451	.004	18	view →
THCA	DFS	Tertile	II,III,IV	0.136	0.764	.008	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MIR6078–STAD (OS)

Open the STAD breakdown →